Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Viridian Therapeutics Inc (NASDAQ: VRDN) closed at $23.33 in the last session, up 1.17% from day before closing price of $23.06. In other words, the price has increased by $1.17 from its previous closing price. On the day, 1.41 million shares were traded. VRDN stock price reached its highest trading level at $23.76 during the session, while it also had its lowest trading level at $22.99.
Ratios:
We take a closer look at VRDN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 23.99 and its Current Ratio is at 23.99. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on September 11, 2024, Reiterated its Buy rating but revised its target price to $38 from $30 previously.
On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $29.
On June 06, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $23.Goldman initiated its Buy rating on June 06, 2024, with a $23 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 13 ’24 when Fairmount Funds Management LLC bought 1,600,000 shares for $18.75 per share. The transaction valued at 30,000,000 led to the insider holds 3,445,813 shares of the business.
Fairmount Funds Management LLC bought 476,190 shares of VRDN for $9,999,990 on Jan 22 ’24. The Director now owns 1,839,954 shares after completing the transaction at $21.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1781396992 and an Enterprise Value of 1141500800. For the stock, the TTM Price-to-Sale (P/S) ratio is 6143.03 while its Price-to-Book (P/B) ratio in mrq is 3.89. Its current Enterprise Value per Revenue stands at 3963.545 whereas that against EBITDA is -4.562.
Stock Price History:
Over the past 52 weeks, VRDN has reached a high of $24.18, while it has fallen to a 52-week low of $10.93. The 50-Day Moving Average of the stock is 38.77%, while the 200-Day Moving Average is calculated to be 39.56%.
Shares Statistics:
According to the various share statistics, VRDN traded on average about 1.49M shares per day over the past 3-months and 1685790 shares per day over the past 10 days. A total of 76.36M shares are outstanding, with a floating share count of 66.40M. Insiders hold about 13.04% of the company’s shares, while institutions hold 82.45% stake in the company. Shares short for VRDN as of 1726185600 were 10461877 with a Short Ratio of 7.03, compared to 1723680000 on 8001614. Therefore, it implies a Short% of Shares Outstanding of 10461877 and a Short% of Float of 15.640001.
